The Science Behind Laser Skin Resurfacing

Last updated: 5 August 2026

What is laser skin resurfacing?

Laser skin resurfacing is a precision technology that uses focused light energy to remove damaged skin layers and stimulate the body’s natural healing response, producing new, healthier tissue. Since its introduction in the 1990s, laser resurfacing has evolved from a single, aggressive modality into a sophisticated spectrum of treatments offering everything from gentle rejuvenation to complete skin renewal.

Practitioners utilise laser technology as part of comprehensive treatment plans, selecting the most appropriate laser type and parameters for each patient’s individual needs, skin type, and recovery capacity. Understanding the science behind these treatments empowers patients to make informed decisions.

How lasers interact with skin

All medical lasers work on the principle of selective photothermolysis, first described by Anderson and Parrish in 1983. This principle states that specific wavelengths of light are preferentially absorbed by specific chromophores (light-absorbing structures) in the skin. The three primary chromophores relevant to skin resurfacing are:

• Water: Absorbed by CO2 (10,600nm) and erbium (2,940nm) lasers. Since the dermis is 70% water, these wavelengths are highly effective at ablating (vaporising) skin tissue.
• Melanin: Absorbed by shorter wavelengths (532nm, 694nm, 755nm). Used for pigmentation treatment.
• Oxyhaemoglobin: Absorbed by wavelengths in the 500–600nm range and around 1064nm. Used for vascular lesion treatment.

Types of laser resurfacing

Ablative Lasers

Ablative lasers vaporise the epidermis and a controlled depth of dermis, triggering complete re-epithelialisation and significant collagen remodelling:

CO2 Laser (10,600nm): The most powerful resurfacing laser. CO2 energy is strongly absorbed by intracellular water, causing immediate tissue vaporisation. Each pass removes approximately 20–30 micrometres of tissue. A systematic review in Dermatologic Surgery (2023) confirmed that CO2 laser resurfacing can achieve wrinkle reduction of 50–80%, improvement in acne scarring of 50–75%, and significant improvement in dyschromia and skin texture. Recovery time is 7–14 days for epithelialisation, with residual erythema lasting 2–6 months.

Erbium:YAG Laser (2,940nm): Erbium lasers have 10–15 times greater affinity for water than CO2, meaning they ablate tissue more precisely with less residual thermal damage (approximately 5–10 micrometres of thermal zone versus 50–100 micrometres for CO2). This results in faster healing (5–7 days), less erythema (4–8 weeks), and lower risk of hypopigmentation, and less dramatic collagen contraction and remodelling. Erbium is preferred for patients seeking moderate improvement with less downtime.

Non-ablative lasers

Non-ablative lasers heat the dermis without destroying the epidermis, stimulating collagen remodelling whilst preserving the skin surface. Key non-ablative wavelengths include:

• Nd:YAG 1320nm and 1064nm: Penetrate deeply into the dermis, stimulating collagen from below.
• Diode 1450nm: Targets dermal water to stimulate collagen production.
• Pulsed dye laser 585/595nm: Targets vascular structures, effective for redness and vascular lesions.

Non-ablative treatments require multiple sessions (typically 4–6) but offer minimal downtime (redness for 24–48 hours). Results are more subtle than ablative treatments, typically 20–35% improvement in wrinkles and texture.

Fractional laser technology

The introduction of fractional photothermolysis by Manstein et al. In 2004 revolutionised laser resurfacing. Rather than treating 100% of the skin surface (as traditional ablative lasers do), fractional lasers create thousands of microscopic treatment zones (microthermal zones or MTZs) surrounded by untreated tissue. This “islands of injury within a sea of normal tissue” approach allows the body to heal much faster, as keratinocytes migrate from the untreated tissue bridges.

Fractional technology is available in both ablative and non-ablative forms:

• Fractional ablative (e.g., fractional CO2): Creates columns of vaporised tissue from the epidermis through to the deep dermis. Treats 15–40% of the skin surface per session. Offers 60–80% of the results of traditional ablative resurfacing with 50–70% less downtime.
• Fractional non-ablative (e.g., 1550nm Fraxel): Creates columns of coagulated (not vaporised) tissue within the dermis, leaving the epidermis intact. Treats 15–25% of the surface per session. Even less downtime (2–5 days of redness and swelling) with results building over 3–5 sessions.

Clinical Applications

Photodamage and Photoageing

Laser resurfacing is one of the most effective treatments for cumulative sun damage. Research in the British Journal of Dermatology (2023) demonstrated that a single fractional CO2 session improved photodamage scores by 45–60%, with histological analysis confirming new collagen deposition extending to 1mm below the treatment zone.

Acne Scarring

Fractional laser has become first-line treatment for atrophic acne scars. A meta-analysis in JAMA Dermatology (2023) found that 3–5 sessions of fractional CO2 laser improved acne scar severity by 50–70%, with results comparable to older, more aggressive fully ablative techniques but with dramatically reduced complication rates.

Pigmentation

Both fractional and non-fractional lasers can address pigmentary concerns, though the approach varies. Q-switched lasers (532nm, 694nm, 1064nm) target melanin directly for discrete pigmented lesions, whilst fractional lasers improve diffuse dyschromia by promoting epidermal turnover and more uniform melanin distribution.

Surgical and traumatic scars

Laser resurfacing has become a standard component of scar management. A consensus paper in Plastic and Reconstructive Surgery (2023) recommended early fractional laser treatment (beginning 4–8 weeks post-injury) to optimise scar remodelling, based on evidence showing 40–60% improvement in scar appearance.

Safety Considerations

Skin type and laser selection

Fitzpatrick skin type significantly influences laser selection and parameters. Darker skin types (IV–VI) are at increased risk of post-inflammatory hyperpigmentation (PIH) and hypopigmentation with ablative lasers. Non-ablative fractional lasers and Nd:YAG wavelengths are generally safer for these skin types. Pre-treatment with topical depigmenting agents and post-treatment sun protection are essential regardless of skin type.

Pre-treatment preparation

• Antiviral prophylaxis (aciclovir or valaciclovir) for any patient with a history of cold sores, starting 1–2 days before treatment
• Discontinuation of retinoids 5–7 days before ablative treatment
• Avoidance of sun exposure and self-tanning products for 4 weeks pre-treatment
• Comprehensive skin assessment including Fitzpatrick typing and melanin density measurement

Post-treatment care

• Gentle cleansing with saline or prescribed wound care solution
• Occlusive ointment (petrolatum-based) for ablative treatments until re-epithelialisation
• Strict sun avoidance and SPF 50 for a minimum of 3 months
• Gradual reintroduction of active skincare ingredients over 4–6 weeks

The future of laser resurfacing

Emerging technologies continue to refine laser resurfacing. Picosecond lasers with diffractive lens arrays create laser-induced optical breakdown (LIOB) without thermal damage, potentially reducing downtime further. Hybrid fractional lasers combining ablative and non-ablative wavelengths in a single pass offer customisable depth profiles. Artificial intelligence-guided parameter selection based on real-time skin analysis is in early clinical trials.

Key Takeaways

• Laser resurfacing works through selective photothermolysis, matching wavelength to tissue target
• Fractional technology has dramatically improved the safety-to-efficacy ratio
• Treatment selection should be based on skin type, concern, and acceptable downtime
• Pre-treatment preparation and post-treatment care are critical for safe outcomes
• Darker skin types require modified laser selection and parameters